Please login to the form below

Not currently logged in
Email:
Password:

Astellas 'Changing Tomorrow' award winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners.

The awards are designed to reward organisations working across all communities to help individuals realise their full potential and enhance their quality of life both now and in the future.

The first four recipients of the award, selected for the life-changing contributions they have made, are:
· CliniClowns – a Dutch organisation which arranges for clowns to visit sick children in hospital
· The International Foundation for Dermatology (IFD) – a non-profit organisation working to improve dermatologic care in rural areas of developing countries
· The Prostate Cancer Charity – the UK's leading voluntary organisation working with people affected by prostate cancer; and
· Save the Children – the Cyclone Nargis, Burma Fund.

Masao Yoshida, president and CEO of Astellas Pharma Europe, said: "Astellas takes its responsibility to society seriously and is committed to changing the lives of people around the world. We support worthwhile causes that make a difference; the four charities chosen to receive the Astellas 'Changing Tomorrow' charity awards are all striving to create a brighter future in their respective fields."

The 'Changing Tomorrow' awards are the latest initiative in Astellas' ethical commitment to support medical research and education on a global level. The company also runs a series of Corporate Social responsibility (CSR) programmes, which includes a registered charity supporting programmes and activities that will lead to a healthy society – the Astellas European Foundation.

Commenting on the award, John Neate, CEO of The Prostate Cancer Charity, said: "The Prostate Cancer Charity is delighted to have received this award and the associated funding. This contribution will help us to continue to raise awareness of prostate cancer and finance research, in addition to providing practical support and information to men affected by prostate cancer, the most common cancer in men in the UK, and their families."

24th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics